| 摘要 |
Disclosed is the use of a composition comprising a human milk oligosaccharide selected from the group consisting of 3’-sialyllactose, 6’-sialyllactose, 2’-fucosyllactose, lacto-N-neotetraose, and combinations thereof, in a concentration of 0.001 mg/mL to 0.2 mg/mL and a carotenoid for the manufacture of a medicament for use in improving airway respiratory health/improving airway defence mechanisms in an infant, toddler, or child. |
